Detalhe da pesquisa
1.
A glycolytic metabolite bypasses "two-hit" tumor suppression by BRCA2.
Cell
; 187(9): 2269-2287.e16, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38608703
2.
Identification of regulators of polyploidization presents therapeutic targets for treatment of AMKL.
Cell
; 150(3): 575-89, 2012 Aug 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-22863010
3.
Targeting hypoxia-inducible factor-1, for cancer treatment: Recent advances in developing small-molecule inhibitors from natural compounds.
Semin Cancer Biol
; 80: 379-390, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33002608
4.
Clinical outcome and prognostic factors for Asian patients in Phase I clinical trials.
Br J Cancer
; 128(8): 1514-1520, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36797357
5.
Extracellular vesicles, the cornerstone of next-generation cancer diagnosis?
Semin Cancer Biol
; 74: 105-120, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33989735
6.
Risk factors for immune-related adverse events from anti-PD-1 or anti-PD-L1 treatment in an Asian cohort of nonsmall cell lung cancer patients.
Int J Cancer
; 150(4): 636-644, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34562273
7.
Phase I study of expanded natural killer cells in combination with cetuximab for recurrent/metastatic nasopharyngeal carcinoma.
Cancer Immunol Immunother
; 71(9): 2277-2286, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35098345
8.
Epstein-Barr virus-induced ectopic CD137 expression helps nasopharyngeal carcinoma to escape immune surveillance and enables targeting by chimeric antigen receptors.
Cancer Immunol Immunother
; 71(11): 2583-2596, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35299256
9.
Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefit.
Cancer Immunol Immunother
; 71(6): 1531-1543, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34661709
10.
Immunohistochemistry study of tumor vascular normalization and anti-angiogenic effects of sunitinib versus bevacizumab prior to dose-dense doxorubicin/cyclophosphamide chemotherapy in HER2-negative breast cancer.
Breast Cancer Res Treat
; 192(1): 131-142, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34928481
11.
Weekly versus tri-weekly paclitaxel with carboplatin for first-line treatment in women with epithelial ovarian cancer.
Cochrane Database Syst Rev
; 2: CD012007, 2022 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35188221
12.
Low-dose pembrolizumab in the treatment of advanced non-small cell lung cancer.
Int J Cancer
; 149(1): 169-176, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33634869
13.
MELK mediates the stability of EZH2 through site-specific phosphorylation in extranodal natural killer/T-cell lymphoma.
Blood
; 134(23): 2046-2058, 2019 12 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31434700
14.
Intracellular vincristine levels in lymphoblasts affect treatment outcome in childhood B-lymphoblastic leukaemia: Ma-Spore ALL 2010 study.
Br J Clin Pharmacol
; 87(4): 1990-1999, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33037681
15.
Targetable BET proteins- and E2F1-dependent transcriptional program maintains the malignancy of glioblastoma.
Proc Natl Acad Sci U S A
; 115(22): E5086-E5095, 2018 05 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29764999
16.
The pleiotropic role of transcription factor STAT3 in oncogenesis and its targeting through natural products for cancer prevention and therapy.
Med Res Rev
; 2020 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33289118
17.
A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours.
BMC Cancer
; 20(1): 1118, 2020 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33203399
18.
A unique CDK4/6 inhibitor: Current and future therapeutic strategies of abemaciclib.
Pharmacol Res
; 156: 104686, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32068118
19.
Bevacizumab Augments the Antitumor Efficacy of Infigratinib in Hepatocellular Carcinoma.
Int J Mol Sci
; 21(24)2020 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33321903
20.
Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy.
Molecules
; 25(20)2020 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33092283